Skip to main content
. 2020 Nov 13;3(3):318–326. doi: 10.1016/j.cjco.2020.10.018

Table 1.

Demographic, clinical, and echocardiographic characteristics

Variables Patients (n = 374)
Age (y), mean ± SD 63.4 ± 12.7
Female, n (%) 93 (25)
Type of atrial fibrillation, n (%)
 Paroxysmal 180 (48)
 Persistent 105 (28)
 Permanent 57 (15)
 Unspecified 32 (9)
CHF, n (%) 93 (25)
Hypertension, n (%) 222 (59)
Age ≥ 75, n (%) 70 (19)
Diabetes mellitus, n (%) 51 (14)
Prior stroke/TIA, n (%) 55 (15)
Vascular disease, n (%) 97 (27)
Age 65-74, n (%) 100 (27)
CHA2DS2-VASc score, mean ± SD 2.4 ± 2.0
 Score 0, n (%) 57 (16)
 Score 1, n (%) 96 (26)
 Score 2-6, n (%) 196 (54)
 Score > 6, n (%) 14 (4)
Spontaneous echocardiographic contrast (SEC), n (%) 200 (54)
 Mild 96 (26)
 Moderate 70 (19)
 Severe 34 (9)
Left atrium appendage thrombus (LAAT), n (%) 19 (5)
Left atrium appendage emptying velocity (cm/s), mean ± SD 46.9 ± 25.2
 ≥ 75, n (%) 52 (17)
 50-74, n (%) 81 (26)
 26-49, n (%) 96 (31)
 ≤ 25, n (%) 78 (25)
Left atrium volume index (cm/m2), mean ± SD 43.3 ± 16.6
 > 60, n (%) 44 (14)
Left ventricular ejection fraction, mean ± SD 54.8 ± 11.6
 < 40%, n (%) 40 (11)
Any atheromas of aorta, n (%) 237 (65)
 Simple 209 (57)
 Severe 28 (8)
VWF activity (IU/dL)
 Mean (SD) 145.9 (51.5)
 Median (min, max) 136.8 (49.2, 375.2)
VWF antigen (IU/dL)
 Mean (SD) 159.6 (53.4)
 Median (min, max) 155.0 (49.0, 399.0)
VWF activity/antigen concentration ratio
 Mean (SD) 0.9 (0.1)
 Median (min, max) 0.9 (0.6, 1.5)
ADAMTS13 activity
 Mean (SD) 115.8 (46.0)
 Median (min, max) 109.3 (30.7, 289.3)

ADAMTS13, a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; CHA2DS2-VASc, Congestive Heart Failure, Hypertension, Age (≥75 years), Diabetes, Stroke/Transient Ischemic Attack, Vascular Disease, Age (65-74 years), Sex (Female); CHF, congestive heart failure; SD, standard deviation; TIA, transient ischemic attack; VWF, Von Willebrand factor.